BKS ADVISORS, LLC - CURE PHARMA HOLDING CORP COM ownership

Back to all holdings Add to watchlist

CURE PHARMA HOLDING CORP COM's ticker is CURR and the CUSIP is 23127P104. A total of 1 filers reported holding CURE PHARMA HOLDING CORP COM in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BKS ADVISORS, LLC ownership history of CURE PHARMA HOLDING CORP COM
ValueSharesWeighting
Q2 2018$101,000
+20.2%
121,240
+130.2%
0.04%
+20.0%
Q4 2017$84,000
-71.0%
52,6650.0%0.03%
-73.5%
Q3 2017$290,000
-31.1%
52,6650.0%0.11%
-33.9%
Q2 2017$421,000
+32.4%
52,665
+23.4%
0.17%
+23.0%
Q1 2017$318,000–42,665–0.14%–
 Download
Other shareholders
CURE PHARMA HOLDING CORP COM shareholders Q2 2018
NameSharesValueWeighting ↓
BKS ADVISORS, LLC 121,240$101,0000.04%
View complete list of CURE PHARMA HOLDING CORP COM shareholders